Vancomycin Infiltrate-Induced Dermatitis Mimicking Bullous Cellulitis

November 2017 | Volume 16 | Issue 11 | Case Reports | 1160 | Copyright © November 2017

Sowmya Nanjappa MD, Matthew Snyder PharmD, and John N. Greene MD FACP

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL


  1. Reynolds, PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Euro J Clin Microbiol Infect Dis. 1989;8:943-950.
  2. Geraci JE. Vancomycin. Mayo Clin Proc. 1977;52:631-634.
  3. Vancomycin [product insert]. Lake Forest, IL: Hospira, Inc; 2010.
  4. Le A, Patel S. Extravasation of noncytotoxic drugs: A review of the literature. Ann Pharmacother. 2014;48:870-886.
  5. Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42 Suppl 1:S5-12.
  6. Moellering RC Jr. Vancomycin: A 50-year reassessment. Clin Infect Dis. 2006;42 Suppl 1:S3-4.
  7. Pitsiouu G, Kioumis I, Zarogoulidis K, et al. Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: A retrospective study. Ann Transl Med. 2015;3:56-62.
  8. Polk RE, Healy DP, Schwartz LB, et al. Vancomycin and the red-man syndrome: Pharmacodynamics of histamine release. J Infect Dis. 1988;157:502-507.
  9. Laurencin CT, Horan RF, Senatus PB, et al. Stevens-Johnson-type reaction with vancomycin treatment. Ann Pharmacother. 1992;26:1520-1521.
  10. Vidal C, González Quintela A, Fuente R. Toxic epidermal necrolysis due to vancomycin. Ann Allergy. 1992;68:345-347.
  11. Felix-Getzik E, Sylvia LM. Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy. 2009;29:846-851.
  12. Young S, Ojaimi S, Dunckley H, et al. Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome. Intern Med J. 2014;44:694-696.
  13. Nousari HC, Costarangos C, Anhalt GJ. Vancomycin-associated linear IgA bullous dermatosis. Ann Intern Med. 1998;129:507-508.
  14. Hoelen DWM, Than DHT, van Vugt R, et al. Severe local vancomycin induced skin necrosis. Br J Clin Pharmacol. 2007;64:553-554.
  15. Bohm NM, Wong JG. Bullous dermatosis associated with vancomycin extravasation. Am J Med Sci. 2012;343:177-179.
  16. Medusa NHS Wales. Management of extravasation: Treatment summary. Available at: Accessed January 17, 2016.
  17. Hurst S, McMillan M. Innovative solutions in critical care units: extravasation guidelines. Dimens Crit Care Nurs. 2004;23:125-128.
  18. Reynolds PM, MacLaren R, Mueller SW, et al. Management of extravasation injuries: A focused evaluation of noncytotoxic medications. Pharmacotherapy. 2014;34:617-632.
  19. Williams L, So J, Buchan A, et al. Management of extravasation policy. Manchester Cancer. Available at: Accessed January 17, 2016.
  20. Al-Benna S, O’Boyle C, Holley J. Extravasation injuries in adults. ISRN Dermatol. 2013;2013:856541.
  21. Payne AS, Savarese DMF. Extravasation injury from chemotherapy and other non-antineoplastic vesicants. UpToDate. Available at: Accessed November 22, 2015.
  22. Ciprofloxacin [product insert]. Lake Forest, IL: Hospira, Inc.; 2013.
  23. Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. Am J Surg. 1979;137:497-506.
  24. Acyclovir [product insert]. Richmond Hill, ON: Pharmaceutical Partners of Canada, Inc.; 2009.
  25. Sulfamethoxazole and trimethoprim [drug label information]. Sellersville, PA: Teva Pharmaceuticals USA; 2013.
  26. Ganciclovir [prescribing information]. South San Francisco, CA: Genentech USA, Inc.;2010.
  27. Doxycycline [package insert]. Schaumburg, IL: APP Pharmaceuticals, LLC: 2008.
  28. Guillet S, Zeller V, Dubée V, et al. Large cohort study of central venous catheter thrombosis during intravenous antibiotic therapy. Antimicrob Agents Chemother. 2015;60:36-43.
  29. Hadaway L, Chamallas SN. Vancomycin: New perspectives on an old drug. J Infus Nurs. 2003;26:278-284.
  30. Edwards J, Green P, Haase D. A blistering disease: Bullous erysipelas. CMAJ. 2006;175:244.


Matthew Snyder PharmD